Everspin Press Releases
View printer-friendly version << Back
Everspin Reports Preliminary Unaudited Fourth Quarter and Full Year 2020 Financial Results
Fourth Quarter and Full Year 2020 Highlights
-
2020 revenue increased 12.1% year-over-year to
$42.0 million -
Q4’20 GAAP net loss per share of (
$0.08 ) was a significant improvement over both the prior quarter and year-ago periods -
Generated
$0.6 million cash flow from operations in Q4’20, the second consecutive quarter with positive cash flow from operations -
Ended 2020 with cash and equivalents of
$14.6 million -
First royalty revenue from
GLOBALFOUNDRIES for embedded MRAM on their 22FDX process in Q4
“We are happy to report that in Q4 we continued our progress towards driving sustainable cash flow from operations. We are continuing to drive our critical R&D programs and key business initiatives, and we believe that we are positioned for profitable growth,” stated
“We are also pleased to report that, in Q1’21, we received a
Preliminary Fourth Quarter 2020 Results
Total revenue for the fourth quarter of 2020 was
GAAP gross margin for the fourth quarter of 2020 was 52.3%, compared to 23.0% in the prior quarter and 53.6% in the fourth quarter of 2019. Fourth quarter of 2020 gross margin included a
GAAP operating expenses for the fourth quarter of 2020 were
In the fourth quarter of 2020, we recorded a
GAAP net loss for the fourth quarter of 2020 was
Adjusted EBITDA for the fourth quarter of 2020 was
Cash and cash equivalents as of
Business Outlook
For the first quarter of 2021,
Preliminary, Unaudited Financial Results
The financial results presented above reflect our preliminary estimates, are based on the information available as of the date hereof and are subject to further review by
Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under generally accepted accounting principles in
Our management and board of directors use Adjusted EBIDTA to understand and evaluate our operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operating and financing plans. Accordingly, our management believes that this non-GAAP measure provide useful information for investors in understanding and evaluating our operating results in the same manner as our management and our board of directors, as well as facilitating comparisons of our operating performance on a period-to-period basis.
Non-GAAP financial measures, including Adjusted EBIDTA, should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Moreover, other companies may define non-GAAP measures differently, which limits the usefulness of these measures for comparisons with such other companies. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.
Conference Call
A telephone replay of the conference call will be available approximately two hours after the call and for 90 days thereafter. The replay can be accessed by dialing 1-855-859-2056 and using the passcode 1537906. International callers should dial +1-404-537-3406 and enter the same passcode at the prompt.
About
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding future results that involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements, including, but not limited to the statements made under the caption “Business Outlook.” Forward-looking statements are identified by words such as “believe”, “will”, “may”, “estimate”, “continue”, “anticipate”, “intend”, “should”, “plan”, “expect”, “predict”, “could”, “potentially" or the negative of these terms or similar expressions. These include, but are not limited to our future plans, strategies, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. Actual results could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, the risks set forth under the caption “Risk Factors” in Everspin’s Quarterly Report on Form 10-Q filed on
|
Condensed Balance Sheets (In thousands, except share and per share amounts) (Unaudited) |
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
|
||||||
|
|
|
2020 |
|
|
2019 |
|||
|
Assets |
|
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
14,599 |
|
|
$ |
14,487 |
|
|
Accounts receivable, net |
|
|
7,607 |
|
|
|
5,799 |
|
|
Inventory |
|
|
5,721 |
|
|
|
7,863 |
|
|
Prepaid expenses and other current assets |
|
|
270 |
|
|
|
539 |
|
|
Total current assets |
|
|
28,197 |
|
|
|
28,688 |
|
|
Property and equipment, net |
|
|
1,946 |
|
|
|
3,479 |
|
|
Right-of-use assets |
|
|
2,313 |
|
|
|
3,132 |
|
|
Other assets |
|
|
73 |
|
|
|
73 |
|
|
Total assets |
|
$ |
32,529 |
|
|
$ |
35,372 |
|
|
|
|
|
|
|
|
|
||
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
|
||
|
Accounts payable |
|
$ |
2,224 |
|
|
$ |
2,873 |
|
|
Accrued liabilities |
|
|
2,461 |
|
|
|
2,727 |
|
|
Current portion of long-term debt |
|
|
4,242 |
|
|
|
670 |
|
|
Operating lease liabilities |
|
|
1,508 |
|
|
|
1,582 |
|
|
Other liabilities |
|
|
31 |
|
|
|
42 |
|
|
Total current liabilities |
|
|
10,466 |
|
|
|
7,894 |
|
|
Long-term debt, net of current portion |
|
|
3,748 |
|
|
|
7,149 |
|
|
Operating lease liabilities, net of current portion |
|
|
903 |
|
|
|
1,840 |
|
|
Total liabilities |
|
|
15,117 |
|
|
|
16,883 |
|
|
Commitments and contingencies |
|
|
|
|
|
|
||
|
Stockholders’ equity: |
|
|
|
|
|
|
||
|
Preferred stock, |
|
|
— |
|
|
|
— |
|
|
Common stock, |
|
|
2 |
|
|
|
2 |
|
|
Additional paid-in capital |
|
|
174,584 |
|
|
|
167,149 |
|
|
Accumulated deficit |
|
|
(157,174 |
) |
|
(148,662 |
) |
|
|
Total stockholders’ equity |
|
|
17,412 |
|
|
|
18,489 |
|
|
Total liabilities and stockholders’ equity |
|
$ |
32,529 |
|
|
$ |
35,372 |
|
|
Condensed Statements of Operations and Comprehensive Loss (In thousands, except share and per share amounts) (Unaudited) |
|||||||||
|
|
|
|
|
|
|
|
|
||
|
|
|
Year Ended |
|||||||
|
|
|
|
|||||||
|
|
|
2020 |
|
2019 |
|
||||
|
Product sales |
|
$ |
39,848 |
|
|
$ |
34,595 |
|
|
|
Licensing, royalty, and other revenue |
|
|
2,183 |
|
|
|
2,908 |
|
|
|
Total revenue |
|
|
42,031 |
|
|
|
37,503 |
|
|
|
Cost of sales |
|
|
23,942 |
|
|
|
19,172 |
|
|
|
Gross profit |
|
|
18,089 |
|
|
|
18,331 |
|
|
|
Operating expenses:1 |
|
|
|
|
|
|
|
||
|
Research and development |
|
|
10,896 |
|
|
|
14,183 |
|
|
|
General and administrative |
|
|
10,773 |
|
|
|
12,414 |
|
|
|
Sales and marketing |
|
|
3,983 |
|
|
|
5,364 |
|
|
|
Restructuring |
|
|
— |
|
|
|
782 |
|
|
|
Total operating expenses |
|
|
25,652 |
|
|
|
32,743 |
|
|
|
Loss from operations |
|
|
(7,563 |
) |
|
|
(14,412 |
) |
|
|
Interest expense |
|
|
(665 |
) |
|
|
(747 |
) |
|
|
Other (expense) income, net |
|
|
(24 |
) |
|
|
490 |
|
|
|
Net loss before income taxes |
|
|
(8,252 |
) |
|
|
(14,669 |
) |
|
|
Income tax expense |
|
|
(260 |
) |
|
|
— |
|
|
|
Net loss and comprehensive loss |
|
$ |
(8,512 |
) |
|
$ |
(14,669 |
) |
|
|
Net loss per common share, basic and diluted |
|
$ |
(0.45 |
) |
|
$ |
(0.85 |
) |
|
|
Weighted-average shares used to compute net loss per common share, basic and diluted |
|
|
18,782,287 |
|
|
|
17,317,042 |
|
|
|
|
|
|
|
|
|
|
|
||
|
1Operating expenses include stock-based compensation as follows: |
|
|
|
|
|
|
|
||
|
Research and development |
|
$ |
903 |
|
|
$ |
736 |
|
|
|
General and administrative |
|
|
2,710 |
|
|
|
2,460 |
|
|
|
Sales and marketing |
|
|
355 |
|
|
|
358 |
|
|
|
Total stock-based compensation |
|
$ |
3,968 |
|
|
$ |
3,554 |
|
|
|
Reconciliation of Adjusted EBITDA (In thousands) (Unaudited) |
|||||||||
|
|
|
|
|||||||
|
|
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|
|
|||
|
Adjusted EBITDA reconciliation: |
|||||||||
|
Net loss |
$ (1,591 |
) |
$ (3,895 |
) |
$ (3,081 |
) |
|||
|
Depreciation and amortization |
370 |
|
799 |
|
397 |
|
|||
|
Stock-based compensation expense |
1,335 |
|
910 |
|
1,157 |
|
|||
|
Interest Expense |
164 |
|
157 |
|
180 |
|
|||
|
Restructuring Expense |
782 |
|
|||||||
|
Adjusted EBITDA |
|
|
$ (2,029 |
) |
$ (565 |
) |
|||
|
Condensed Statement of Cash Flows (In thousands) (Unaudited) |
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
Year Ended |
||||||
|
|
|
|
||||||
|
|
|
2020 |
|
2019 |
||||
|
Cash flows from operating activities |
|
|
|
|
|
|
||
|
Net loss |
|
$ |
(8,512 |
) |
|
$ |
(14,669 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
1,982 |
|
|
|
1,694 |
|
|
Loss on disposal of property and equipment |
|
|
30 |
|
|
|
20 |
|
|
Stock-based compensation |
|
|
3,968 |
|
|
|
3,554 |
|
|
Non-cash gain on warrant revaluation |
|
|
(2 |
) |
|
|
(3 |
) |
|
Non-cash interest expense |
|
|
323 |
|
|
|
290 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
|
Accounts receivable |
|
|
(1,808 |
) |
|
|
1,723 |
|
|
Inventory |
|
|
2,142 |
|
|
|
1,234 |
|
|
Prepaid expenses and other current assets |
|
|
269 |
|
|
|
149 |
|
|
Accounts payable |
|
|
(820 |
) |
|
|
202 |
|
|
Accrued liabilities |
|
|
(303 |
) |
|
|
(2,210 |
) |
|
Lease liabilities |
|
|
(192 |
) |
|
|
(100 |
) |
|
Net cash used in operating activities |
|
|
(2,923 |
) |
|
|
(8,116 |
) |
|
Cash flows from investing activities |
|
|
|
|
|
|
||
|
Purchases of property and equipment |
|
|
(320 |
) |
|
|
(861 |
) |
|
Net cash used in investing activities |
|
|
(320 |
) |
|
|
(861 |
) |
|
Cash flows from financing activities |
|
|
|
|
|
|
||
|
Payments on debt |
|
|
— |
|
|
|
(4,840 |
) |
|
Payments of debt issuance costs |
|
|
— |
|
|
|
(80 |
) |
|
Payments on finance lease obligation |
|
|
(9 |
) |
|
|
(11 |
) |
|
Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan |
|
|
1,280 |
|
|
|
282 |
|
|
Proceeds from issuance of common stock in at-the-market offering, net of issuance costs |
|
|
2,084 |
|
|
|
4,734 |
|
|
Net cash provided by financing activities |
|
|
3,355 |
|
|
|
85 |
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
112 |
|
|
|
(8,892 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
14,487 |
|
|
|
23,379 |
|
|
Cash and cash equivalents at end of period |
|
$ |
14,599 |
|
|
$ |
14,487 |
|
|
Supplementary cash flow information: |
|
|
|
|
|
|
||
|
Interest paid |
|
$ |
342 |
|
|
$ |
480 |
|
|
Cash paid for taxes |
|
$ |
— |
|
|
$ |
48 |
|
|
Operating cash flows paid for operating leases |
|
$ |
1,736 |
|
|
$ |
1,693 |
|
|
Financing cash flows paid for finance leases |
|
$ |
9 |
|
|
$ |
11 |
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
||
|
Right-of-use assets obtained in exchange for new operating leases |
|
$ |
— |
|
|
$ |
23 |
|
|
Increase of right-of-use asset and lease liability due to lease modification |
|
$ |
545 |
|
|
$ |
895 |
|
|
Purchases of property and equipment in accounts payable and accrued liabilities |
|
$ |
216 |
|
|
$ |
57 |
|
|
Bonus settled in restricted stock units |
|
$ |
(49 |
) |
|
$ |
— |
|
|
Modification of warrant |
|
$ |
— |
|
|
$ |
36 |
|
|
Issuance of warrant with debt |
|
$ |
152 |
|
|
$ |
— |
|
|
Condensed Statements of Operations and Comprehensive Loss (In thousands, except share and per share amounts) (Unaudited) |
||||||||
|
|
|
|
||||||
|
|
|
Three Months Ended |
||||||
|
|
|
|
||||||
|
|
|
2020 |
|
|
2019 |
|
||
|
Product sales |
$ |
9,709 |
|
$ |
9,199 |
|
||
|
Licensing, royalty, and other revenue |
|
268 |
|
|
454 |
|
||
|
Total revenue |
|
9,977 |
|
|
9,653 |
|
||
|
Cost of sales |
|
4,759 |
|
|
4,480 |
|
||
|
Gross profit |
|
5,218 |
|
|
5,173 |
|
||
|
Operating expenses:1 |
|
|
|
|
||||
|
Research and development |
|
2,513 |
|
|
3,271 |
|
||
|
General and administrative |
|
2,976 |
|
|
2,913 |
|
||
|
Sales and marketing |
|
912 |
|
|
1,270 |
|
||
|
Restructuring |
|
|
|
782 |
|
|||
|
Total operating expenses |
|
6,401 |
|
|
8,236 |
|
||
|
Loss from operations |
|
(1,183 |
) |
|
(3,063 |
) |
||
|
Interest expense |
|
(164 |
) |
|
(180 |
) |
||
|
Other (expense) income, net |
16 |
|
163 |
|
||||
|
Loss before Income Taxes |
|
(1,331 |
) |
|
(3,081 |
) |
||
|
Income tax expense |
|
(260 |
) |
|
|
|||
|
Net loss and comprehensive loss |
$ |
(1,591 |
) |
$ |
(3,081 |
) |
||
|
|
|
|
|
|||||
|
Net loss per common share, basic and diluted |
$ |
(0.08 |
) |
$ |
(0.18 |
) |
||
|
Weighted-average shares used to compute net loss per common share, basic and diluted |
|
18,782,287 |
|
|
17,317,042 |
|
||
|
1Operating expenses include stock-based compensation as follows: |
||||||||
|
Research and development |
$ |
365 |
|
$ |
768 |
|
||
|
General and administrative |
822 |
|
137 |
|
||||
|
Sales and marketing |
|
148 |
|
|
167 |
|
||
|
Total stock-based compensation |
$ |
1,335 |
|
$ |
1,072 |
|
||
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225006144/en/
Company Contact:
T: 480-347-1099
E: daniel.berenbaum@everspin.com
Source: